Biogen Inc. (BIIB)

Trade BIIB now with
10/18/2017 7:31:17 AM Biogen Confirms Comprehensive Approach To Tackle Multiple Sclerosis
10/10/2017 7:04:35 AM Align Biopharma Introduces New Technology Standard To Enable Single Sign-on For Healthcare Providers
10/5/2017 7:35:43 AM Biogen: New Data Showing Earlier Initiation Of Treatment With SPINRAZA May Improve Motor Function In Infants With SMA
9/12/2017 7:30:40 AM Biogen Appointms Sanjay Jariwala As SVP, Worldwide Medical
8/28/2017 7:33:22 AM Biogen Reports New Data From Phase 1b Study Of Investigational Alzheimer’s Disease Treatment Aducanumab
8/17/2017 7:24:59 AM Race For A New Alzheimer's Drug
8/10/2017 7:04:04 AM AGTC Files IND For X-linked Retinitis Pigmentosa Caused By Mutations In The RPGR Gene
7/31/2017 9:01:01 AM Biogen Appoints Anabella Villalobos SVP, Biotherapeutic & Medicinal Sciences
7/25/2017 6:37:06 AM Biogen Inc. (BIIB) Has Raised Its FY17 EPS Estimate To 20.80 - 21.40 From 20.45 - 21.25
7/25/2017 6:35:02 AM Biogen Inc. Q2 Income Falls 6%
7/25/2017 6:31:03 AM Biogen Q2 Non-GAAP EPS $5.04; GAAP EPS $4.07